Ari Kellen
Experienced Healthcare Executive in Montreal, Québec, Canada
A healthcare advisor and investor, Dr. Ari Kellen has been offering strategic assistance and funding to organizations in the healthcare industry since 2017. A strategic advisor to early-stage healthcare businesses in the US, Israel, and Europe, he advises a variety of firms, including Nouri Life. In 2018, Dr. Ari Kellen became a strategic advisor for the nanoencapsulation drug-delivery company BioNanoSim. Moreover, he belongs to the board of Vaxil Bio Therapeutics and Theraclion.
Beyond his advisory and investment activities, he has served in a leadership capacity with a wide range of entities in the healthcare sector. Previously, Dr. Kellen led the global segment of a worldwide provider of eye-care products with a history of driving technological advancements for optical equipment.
Drawing on over 30 years of experience in the healthcare industry, Dr. Ari Kellen graduated with a master of business administration and a bachelor of medicine and bachelor of surgery from the University of the Witwatersrand in South Africa.